Atopic dermatitis: Is there a role for probiotics?

Journal of Biological Regulators and Homeostatic Agents

Volumn 29, Issue 2, 2015, Pages 18-24

  Licari, A ^a   Marseglia, A ^a   Castellazzi, A M ^a   Ricci, A ^a   Tagliacarne, C ^a   Valsecchi, C ^a   Castagnoli, R ^a   Marseglia, G L ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ADAPTIVE IMMUNITY; ARTICLE; ATOPIC DERMATITIS; DRUG EFFICACY; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; MICROFLORA; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

EID: 84985990768     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014;134:769-779.
2. Carroll CL, Balkrishnan R, Feldman SR, Fleischer Jr AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005;22:192-199.
3. von Mutius E. The environmental predictors of allergic disease. J Allergy Clin Immunol 2000;105:9-19.
4. Thomsen SF, Ulrik CS, Kyvik KO, et al. Importance of genetic factors in the etiology of atopic dermatitis: a twin study. Allergy Asthma Proc 2007;28:535-539.
5. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007;39:650-654.
6. Böhme M, Söderhöll C, Kull I, Bergström A, van Hage M, Wahlgren C. Filaggrin mutations increase the risk for persistent dry skin and eczema independent of sensitization. J Allergy Clin Immunol 2012;129:1153-5.
7. Salpietro C, Rigoli L, Miraglia Del Giudice M, et al. TLR2 and TLR4 gene polymorphisms and atopic dermatitis in Italian children: a multicenter study. Int J Immunopathol Pharmacol. 2011 Oct; 24(4 Suppl):33-40.
8. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-876.
9. Gittler J, Shemer A, Suàrez-Farinas M, Fuentes-Duculan J, et al. Progressive activation of T (H) 2/T (H) 22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012;130:1344-54.
10. Ciprandi G, De Amici M, Berardi L, Vignini M, Caimmi S, Marseglia A, Marseglia G, Fuchs D. Serum neopterin levels in spontaneous urticaria and atopic dermatitis. Clin Exp Dermatol. 2011 Jan; 36(1):85-7.
11. Marseglia GL, De Amici M, Marseglia A, et al. Pentraxin 3 serum levels in children with atopic dermatitis. J Biol Regul Homeost Agents 2012;26:S105-108.
12. Ciprandi G, De Amici M, Giunta V, Marseglia A, Marseglia G. Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol 2013;30:222-225.
13. Wolter S, Price HN. Atopic dermatitis. Pediatr Clin North Am 2014;61:241-260.
14. Marseglia A, Licari A, Agostinis F, Barcella A, Bonamonte D, Puviani M, Milani M, Marseglia G. Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial. Pediatr Allergy Immunol 2014;25:271-275.
15. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar. 27;157(1):121-41.
16. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Health and Nutritional Properlies of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. FAO Food and Nutrition paper 2001;85:1-50.
17. Del Giudice MM, Leonardi S, Ciprandi G, Galdo F, Gubitosi A, La Rosa M, Salpietro C, Marseglia G, Perrone L. Probiotics in childhood: allergic illness and respiratory infections. J Clin Gastroenterol 2012;46:S69-72.
18. Bienenstock J, Gibson G, Klaenhammer TR, Walker WA, Neish AS. New insights into probiotic mechanisms: a harvest from functional and metagenomic studies. Gut Microbes 2013;4:94-100.
19. Valsecchi C, Marseglia A, Ricci A, Montagna L, Leone M, Marseglia GL, Castellazzi AM. Probiotics and children: is an integration useful in allergic diseases? Pediatr Med Chir 2008;30:197-203.
20. Castellazzi AM, Valsecchi C, Caimmi S, et al. Probiotics and food allergy. Ital J Pediatr 2013;39:47.
21. Valsecchi C, Marseglia A, Montagna L, Tagliacarne SC, Elli M, Licari A, Marseglia GL, Castellazzi AM. Evaluation of the effects of a probiotic supplementation with respect to placebo on intestinal microfora and secretory IgA production, during antibiotic therapy, in children affected by recurrent airway infections and skin symptoms. J Biol Regul Homeost Agents 2014;28:117-124.
22. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 2001 Apr. 7;357(9262):1076-9.
23. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet. 2003 May 31;361(9372):1869-71.
24. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebocontrolled trial. J Allergy Clin Immunol. 2007 Apr; 119(4):1019-21.
25. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev. 2007 Oct. 17; (4): CD006475.
26. Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J; Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008 Oct.; 122(4):788-94.
27. Wickens K, Black P, Stanley TV, Mitchell E, Barthow C, Fitzharris P, Purdie G, Crane J. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012 Jul; 42(7):1071-9.
28. Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G, Siebers R, Black PN, Crane J. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy. 2013 Sep; 43(9):1048-57.
29. van der Aa LB, Heymans HS, van Aalderen WM, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol. 2010 Mar;21(2 Pt 2):e355-67.
30. Boyle RJ, Ismail IH, Kivivuori S, Licciardi P V, Robins-Browne RM, Mah LJ, Axelrad C, Moore S, Donath S, Carlin JB, Lahtinen SJ, Tang ML. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011 Apr; 66(4):509-16.
31. Ou CY, Kuo HC, Wang L, Hsu TY, Chuang H, Liu CA, Chang JC, Yu HR, Yang KD. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, doubleblind, placebo-controlled trial. Clin Exp Allergy. 2012 Sep; 42(9):1386-96.
32. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012 Dec; 130(6):1355-60.
33. Bertelsen RJ, Brantsæter AL, Magnus MC, Haugen M, Myhre R, Jacobsson B, Longnecker MP, Meltzer HM, London SJ. Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J Allergy Clin Immunol. 2014 Jan; 133(1):165-71.e1-8.
34. Panduru M, Panduru NM, Salavastru CM, Tiplica GS. Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol. 2014 Apr. 4.
35. Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, Cocco R, Dreborg S, Goodman R, Kuitunen M, Haahtela T, Heine RG, Lack G, Osborn DA, Sampson H, Tannock GW, Lee BW; WAO Special Committee on Food Allergy and Nutrition. Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper. World Allergy Organ J. 2012 Nov; 5(11):148-67.
36. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008 Jan; 121(1):116 121.e11.
37. Michail SK, Stolf A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol. 2008 Nov; 101(5):508-16.
38. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008 Oct. 8; (4): CD006135.
39. Han Y, Kim B, Ban J, Lee J, Kim BJ, Choi BS, Hwang S, Ahn K, Kim J. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr Allergy Immunol. 2012 Nov; 23(7):667-73.
40. Drago L, Toscano M, De Vecchi E, Piconi S, Iemoli E. Changing of fecal fora and clinical effect of L.salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol. 2012 Oct; 46 Suppl: S56-63.
41. Iemoli E, Trabattoni D, Parisotto S, Borgonovo L, Toscano M, Rizzardini G, Clerici M, Ricci E, Fusi A, De Vecchi E, Piconi S, Drago L. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol. 2012 Oct; 46 Suppl:S33-40.